Gilead Sciences (GILD) shares outstanding: 1.24B
Gilead Sciences had 1.24B shares outstanding on Oct 23, 2026, down 0.0% from 1.24B a year earlier.
From Gilead Sciences's filings with the SEC · GILD stock page
Gilead Sciences shares outstanding by year
#79 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 23, 2026 | 1.24B | No change |
| Oct 31, 2025 | 1.24B | -0% |
| Oct 31, 2024 | 1.25B | No change |
| Oct 31, 2023 | 1.25B | -1% |
| Oct 31, 2022 | 1.25B | – |
Shares outstanding of similar companies
Companies in the same industry as Gilead Sciences, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Gilead Sciences | 1.24B | Oct 23, 2026 |
| ImmunityBio | 1.06B | Nov 3, 2026 |
| Recursion Pharmaceuticals | 622.8M | Oct 26, 2026 |
| Amgen | 540.9M | Oct 29, 2026 |
| Iovance Biotherapeutics | 462.7M | Oct 27, 2026 |
| Moderna | 404.6M | Oct 30, 2026 |
| Taysha Gene Therapies | 326.0M | Nov 12, 2026 |
Questions and answers
What is Gilead Sciences's shares outstanding?
Gilead Sciences had 1.24B shares outstanding on Oct 23, 2026, down 0.0% from 1.24B a year earlier.
Numbers as reported in Gilead Sciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology